WIPO WIPO 2008

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke wurde als Bildmarke am 14.02.2008 bei der Weltorganisation für geistiges Eigentum angemeldet.

Logodesign (Wiener Klassifikation)

#Kreise #Inschriften in chinesischen, japanischen oder koreanischen Schriftzeichen #Kreise mit anderen figurativen Elementen #28.03.00

Markendetails Letztes Update: 20. März 2018

Markenform Bildmarke
Aktenzeichen 1003607
Länder Europäische Gemeinschaft Südkorea Singapur
Basismarke CN Nr. 5837848, 10. Januar 2007
Anmeldedatum 14. Februar 2008
Ablaufdatum 14. Februar 2028

Markeninhaber

No. 238, Tianshan Street,
Hi-tech. Development District,
CN

Markenvertreter

7th Floor, Scitech Place, No. 22, Jian Guo Men Wai Ave. CN

Waren und Dienstleistungen

05 Cardiovascular system medication such as for anti-hypertension, for treatment heart failure and for infectious diseases; medication for nutrition metabolism barrier diseases such as malnutrition and beriberi; medication for metabolism diseases such as diabetes, obesity, diabetic ketoacidosis, hypoxemia DKA and high fat proteinemia; medication for endocrine system diseases such as next cerebral ganglion pituitary gland sickness, thyroid gland sickness, ophoropathy and parathyroid sickness; medication for circulatory system diseases such as shock, heart valve sickness, arrhythmia, arteriosclerosis, cardiomyopathy periphery blood vessel disease, hypertensive disease and pericarditis; medication for respiratory disorder such as chronic bronchitis, bronchial asthma, disease of pulmonary circulation, pneumonia and acute trachea bronchitis; medication for digesting system diseases such as abdominal pain, constipation, diarrhea, cholecystitus, liver cirrhosis, liver function failure and gastritis; medication for urinary system diseases such as kidney stone, renal tumor, chronic kidney function failure, urinary tract infection and cystonephrosis; medication for hematopoietic system diseases such as anemia, leukemia and lymphoma; medication for immune system diseases such as serum sickness, allergic shock and allergic rhinitis; medication for rheumatic diseases and osteoarthritis such as rheumatic fever, lupus erythematosus, sjogren's syndrome, behcet disease and dermatomyositis; medication for nerve diseases such as schizophrenia and neurosis; medication for nervous system diseases such as headache, multiple sclerosis and muscle diseases; medication for skin diseases such as eczema, belt-shaped blister measles namely, HERPES ZOSTER (a kind of skin disease), connective tissue disease, lupus erythematosus and nervous dermatitis; medication for reproductive system inflammation such as pelvic inflammatory disease, cervicitis and vestibule big gland inflammation; medication for natural dissemination diseases such as gonorrhea, syphilis and AIDS; medication for female reproductive system tumor such as sarcoma uteri, carcinoma of cervix and endometrium cancer; medication for menopathy such as menopause, painful menstruation and menopause syndrome; medication for newborn symptom and diseases such as the newborn faints from fright, newborn vomit and newborn septicaemia; medication for surgical department diseases such as tetanus, wound and tumor.
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
14. Februar 2018 2018/9 Gaz Verlängerung
13. Juli 2017 2017/29 Gaz US RAW: Total Invalidation
28. Juli 2010 2013/3 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
18. Juni 2010 2010/25 Gaz KR Ablehnung
11. Mai 2010 2010/19 Gaz EM Ablehnung
10. Februar 2010 2013/2 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
13. Juli 2009 2009/30 Gaz SG Ablehnung
30. Juni 2009 2009/28 Gaz US Ablehnung
14. Februar 2008 CN Eintragung
Teilweise Löschung

ID: 141003607